LOS ANGELES, Jan. 28, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ESSA Pharma Inc. ("ESSA" or "the Company") (NASDAQ: EPIX) for violations of §§10(b) and 20(a) of the Securities Exchange Act...
Read More Details
Finally We wish PressBee provided you with enough information of ( EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm )
Also on site :